• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[中国大陆孕中期唐氏综合征血清学筛查:一项多中心前瞻性研究]

[Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study].

作者信息

Bian Xu-Ming, Liu Jun-Tao, Qi Qing-Wei, Jiang Yu-Lin, Li Yan, Liu Shan-Ying, Hao Na, Zhou Jing, Lü Shi-Ming, Zhu Bao-Sheng, Wang He, Xu Zheng-Feng, Pan Xiao-Ying, Liao Can, Cai Yan, Wang Hua, Wang Ze, Zhu Jun, Hu Ya-Li

机构信息

Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing 100730, China.

出版信息

Zhonghua Fu Chan Ke Za Zhi. 2008 Nov;43(11):805-9.

PMID:19087560
Abstract

OBJECTIVE

To evaluate the performance characteristics of the second trimester double-marker test for the detection of fetal Down's syndrome in mainland China.

METHODS

This prospective national multi-centered study used alpha-fetoprotein (AFP) and free beta-subunit of human chorionic gonadotrophin (free beta-hCG) as the serum markers. From May 2004 to September 2006, 11 centers participated in the collection and analysis of maternal serum AFP and free beta-hCG between 14 and 20(+6) weeks of pregnancy. The screening results were calculated using the standard algorithm based on the standard database provided with the analytic software. Patients with an increased risk of Down's syndrome pregnancy (> or = 1/270) were offered genetic amniocentesis. Outcomes of all pregnancies were obtained.

RESULTS

A total of 66 132 singleton pregnancies were included in the study. The median maternal age was 27 years. At a cut-off of 1 in 270, the detection rate (DR) based on a Caucasian database was 72% corresponding to a false positive rate (FPR) of 5%, and the DR based on the Chinese database was raised to 76% corresponding to an FPR of 5%.

CONCLUSION

The double-marker test using AFP and free beta-hCG is an effective screen strategy for second-trimester detection of fetal Down's syndrome in mainland China. Ethnic variance exists between the Caucasian and Chinese populations. The accuracy of screening is increased by the use of race-specific medians.

摘要

目的

评估孕中期二联筛查试验在中国内地检测胎儿唐氏综合征的性能特征。

方法

这项前瞻性全国多中心研究采用甲胎蛋白(AFP)和人绒毛膜促性腺激素游离β亚基(游离β-hCG)作为血清标志物。2004年5月至2006年9月,11个中心参与了孕14至20(+6)周孕妇血清AFP和游离β-hCG的收集与分析。筛查结果使用基于分析软件所提供标准数据库的标准算法进行计算。对唐氏综合征妊娠风险增加(≥1/270)的患者提供遗传羊膜腔穿刺术。获取所有妊娠结局。

结果

本研究共纳入66132例单胎妊娠。孕妇年龄中位数为27岁。以1/270为临界值,基于白种人数据库的检测率(DR)为72%,假阳性率(FPR)为5%;基于中国数据库的DR提高到76%,FPR为5%。

结论

使用AFP和游离β-hCG的二联筛查试验是中国内地孕中期检测胎儿唐氏综合征的有效筛查策略。白种人和中国人群之间存在种族差异。使用种族特异性中位数可提高筛查准确性。

相似文献

1
[Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study].[中国大陆孕中期唐氏综合征血清学筛查:一项多中心前瞻性研究]
Zhonghua Fu Chan Ke Za Zhi. 2008 Nov;43(11):805-9.
2
[Second trimester maternal serum screening for Down's syndrome in women of advanced maternal age: a multi-center prospective study].高龄孕妇孕中期血清学筛查唐氏综合征:一项多中心前瞻性研究
Zhonghua Fu Chan Ke Za Zhi. 2008 Oct;43(10):737-41.
3
[Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].[孕中期使用母体血清生化指标进行唐氏综合征筛查方法的评估]
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Jun;28(3):332-5. doi: 10.3760/cma.j.issn.1003-9406.2011.03.021.
4
Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.亚洲人结合血清游离β-人绒毛膜促性腺激素和甲胎蛋白与孕妇年龄进行唐氏综合征筛查策略的比较。
Prenat Diagn. 1997 Aug;17(8):707-16.
5
[Screening by maternal serum markers for Down's syndrome].[通过母体血清标志物筛查唐氏综合征]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Apr;25(2):156-9.
6
Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.二聚体抑制素A作为孕早期唐氏综合征的标志物。
N Engl J Med. 1996 May 9;334(19):1231-6. doi: 10.1056/NEJM199605093341904.
7
Effectiveness of combining maternal serum alpha-fetoprotein and hCG in a second-trimester screening program for Down syndrome.孕中期唐氏综合征筛查项目中联合母体血清甲胎蛋白和人绒毛膜促性腺激素的有效性。
Obstet Gynecol. 1994 Aug;84(2):298-303.
8
First-trimester or second-trimester screening, or both, for Down's syndrome.孕早期或孕中期唐氏综合征筛查,或两者皆做。
N Engl J Med. 2005 Nov 10;353(19):2001-11. doi: 10.1056/NEJMoa043693.
9
Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population.中孕期序贯三联筛查唐氏综合征的可行性研究:中国大陆人群的一项研究。
Prenat Diagn. 2010 Jan;30(1):74-6. doi: 10.1002/pd.2412.
10
Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.双胎妊娠中期唐氏综合征母体血清筛查:绒毛膜性的影响
Prenat Diagn. 2003 Apr;23(4):331-5. doi: 10.1002/pd.594.

引用本文的文献

1
Current situation and development of prenatal diagnosis in China.中国产前诊断的现状与发展
Front Med China. 2010 Sep;4(3):271-4. doi: 10.1007/s11684-010-0100-z. Epub 2010 Aug 10.